nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CYP2D6—urine—polycystic ovary syndrome	0.0307	0.083	CbGeAlD
Tetrabenazine—CBR1—adrenal cortex—polycystic ovary syndrome	0.0283	0.0766	CbGeAlD
Tetrabenazine—CBR1—endometrium—polycystic ovary syndrome	0.0253	0.0684	CbGeAlD
Tetrabenazine—CBR1—uterus—polycystic ovary syndrome	0.0233	0.063	CbGeAlD
Tetrabenazine—CBR1—pituitary gland—polycystic ovary syndrome	0.0229	0.0619	CbGeAlD
Tetrabenazine—CBR1—adipose tissue—polycystic ovary syndrome	0.0228	0.0616	CbGeAlD
Tetrabenazine—SLC18A2—endometrium—polycystic ovary syndrome	0.0218	0.0588	CbGeAlD
Tetrabenazine—Hypothermia—Metformin—polycystic ovary syndrome	0.0211	0.123	CcSEcCtD
Tetrabenazine—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0211	0.123	CcSEcCtD
Tetrabenazine—CBR1—adrenal gland—polycystic ovary syndrome	0.0205	0.0553	CbGeAlD
Tetrabenazine—SLC18A2—uterus—polycystic ovary syndrome	0.02	0.0541	CbGeAlD
Tetrabenazine—SLC18A2—adipose tissue—polycystic ovary syndrome	0.0196	0.053	CbGeAlD
Tetrabenazine—CBR1—female gonad—polycystic ovary syndrome	0.0191	0.0515	CbGeAlD
Tetrabenazine—CBR1—vagina—polycystic ovary syndrome	0.019	0.0512	CbGeAlD
Tetrabenazine—CBR1—endocrine gland—polycystic ovary syndrome	0.0177	0.0479	CbGeAlD
Tetrabenazine—SLC18A2—adrenal gland—polycystic ovary syndrome	0.0176	0.0475	CbGeAlD
Tetrabenazine—SLC18A2—vagina—polycystic ovary syndrome	0.0163	0.044	CbGeAlD
Tetrabenazine—SLC18A2—endocrine gland—polycystic ovary syndrome	0.0153	0.0412	CbGeAlD
Tetrabenazine—Blood disorder—Metformin—polycystic ovary syndrome	0.0141	0.0824	CcSEcCtD
Tetrabenazine—DRD2—pituitary gland—polycystic ovary syndrome	0.0109	0.0296	CbGeAlD
Tetrabenazine—DRD2—endocrine gland—polycystic ovary syndrome	0.00848	0.0229	CbGeAlD
Tetrabenazine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00783	0.0456	CcSEcCtD
Tetrabenazine—Breast disorder—Metformin—polycystic ovary syndrome	0.00774	0.0451	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00688	0.0401	CcSEcCtD
Tetrabenazine—Drowsiness—Metformin—polycystic ovary syndrome	0.0066	0.0385	CcSEcCtD
Tetrabenazine—Bradycardia—Metformin—polycystic ovary syndrome	0.00603	0.0352	CcSEcCtD
Tetrabenazine—Eye disorder—Metformin—polycystic ovary syndrome	0.00554	0.0323	CcSEcCtD
Tetrabenazine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0055	0.0321	CcSEcCtD
Tetrabenazine—CYP2D6—female gonad—polycystic ovary syndrome	0.00548	0.0148	CbGeAlD
Tetrabenazine—Angiopathy—Metformin—polycystic ovary syndrome	0.00538	0.0313	CcSEcCtD
Tetrabenazine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.0051	0.0138	CbGeAlD
Tetrabenazine—Tremor—Metformin—polycystic ovary syndrome	0.00483	0.0282	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00436	0.0254	CcSEcCtD
Tetrabenazine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00413	0.0241	CcSEcCtD
Tetrabenazine—Skin disorder—Metformin—polycystic ovary syndrome	0.00409	0.0238	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00407	0.0237	CcSEcCtD
Tetrabenazine—Hypotension—Metformin—polycystic ovary syndrome	0.00394	0.0229	CcSEcCtD
Tetrabenazine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00375	0.0219	CcSEcCtD
Tetrabenazine—Somnolence—Metformin—polycystic ovary syndrome	0.00374	0.0218	CcSEcCtD
Tetrabenazine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00366	0.0213	CcSEcCtD
Tetrabenazine—Fatigue—Metformin—polycystic ovary syndrome	0.00363	0.0212	CcSEcCtD
Tetrabenazine—Constipation—Metformin—polycystic ovary syndrome	0.0036	0.021	CcSEcCtD
Tetrabenazine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00347	0.0202	CcSEcCtD
Tetrabenazine—Asthenia—Metformin—polycystic ovary syndrome	0.00302	0.0176	CcSEcCtD
Tetrabenazine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00288	0.0168	CcSEcCtD
Tetrabenazine—Dizziness—Metformin—polycystic ovary syndrome	0.00278	0.0162	CcSEcCtD
Tetrabenazine—Vomiting—Metformin—polycystic ovary syndrome	0.00268	0.0156	CcSEcCtD
Tetrabenazine—Headache—Metformin—polycystic ovary syndrome	0.00264	0.0154	CcSEcCtD
Tetrabenazine—Nausea—Metformin—polycystic ovary syndrome	0.0025	0.0146	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00223	0.00486	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00219	0.00478	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—PTGER3—polycystic ovary syndrome	0.00217	0.00474	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00212	0.00462	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.00207	0.00451	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—STAR—polycystic ovary syndrome	0.00202	0.00441	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.00201	0.0044	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.00201	0.0044	CbGpPWpGaD
Tetrabenazine—CYP2D6—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.00197	0.00429	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00194	0.00424	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.00188	0.00411	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00185	0.00405	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—SRD5A1—polycystic ovary syndrome	0.00184	0.00402	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00183	0.004	CbGpPWpGaD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00183	0.00399	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.00183	0.00399	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.00178	0.00388	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—STAR—polycystic ovary syndrome	0.00176	0.00383	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00174	0.00379	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00173	0.00379	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00173	0.00377	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00173	0.00377	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00172	0.00376	CbGpPWpGaD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.0017	0.00371	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—DLG4—polycystic ovary syndrome	0.00162	0.00354	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00161	0.00352	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00161	0.00351	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00157	0.00344	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00157	0.00342	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—HMMR—polycystic ovary syndrome	0.00156	0.00341	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00152	0.00333	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.0015	0.00328	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—HSD3B1—polycystic ovary syndrome	0.00149	0.00326	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00148	0.00322	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00147	0.00322	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—MTNR1B—polycystic ovary syndrome	0.0014	0.00306	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.0014	0.00305	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.0014	0.00305	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00136	0.00298	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—LHB—polycystic ovary syndrome	0.00136	0.00297	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00135	0.00294	CbGpPWpGaD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00135	0.00294	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—HSD3B2—polycystic ovary syndrome	0.00133	0.0029	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00131	0.00287	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00131	0.00287	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.0013	0.00283	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00129	0.00281	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00126	0.00276	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.00124	0.0027	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00123	0.00268	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.00122	0.00267	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00119	0.0026	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—SULT2A1—polycystic ovary syndrome	0.00119	0.00259	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00116	0.00253	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00116	0.00252	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—RRM2—polycystic ovary syndrome	0.00115	0.00251	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00115	0.0025	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.00111	0.00243	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00111	0.00243	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—YAP1—polycystic ovary syndrome	0.00111	0.00242	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00111	0.00241	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.0011	0.0024	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.0011	0.0024	CbGpPWpGaD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00109	0.00237	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00107	0.00234	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—NAMPT—polycystic ovary syndrome	0.00106	0.00232	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00106	0.00231	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP11A1—polycystic ovary syndrome	0.00105	0.00229	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.00104	0.00228	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.00103	0.00226	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.001	0.00219	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000992	0.00216	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000982	0.00214	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000976	0.00213	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TH—polycystic ovary syndrome	0.000972	0.00212	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000966	0.00211	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000962	0.0021	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000961	0.0021	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00091	0.00199	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000901	0.00197	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000893	0.00195	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000891	0.00195	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00089	0.00194	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000889	0.00194	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00088	0.00192	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000847	0.00185	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—TH—polycystic ovary syndrome	0.000845	0.00184	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000837	0.00183	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000822	0.00179	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00082	0.00179	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000818	0.00178	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000817	0.00178	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000808	0.00176	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000805	0.00176	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000798	0.00174	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000788	0.00172	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000788	0.00172	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000787	0.00172	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000784	0.00171	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000773	0.00169	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.000756	0.00165	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000748	0.00163	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000744	0.00162	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000743	0.00162	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000743	0.00162	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000742	0.00162	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000732	0.0016	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000731	0.00159	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000725	0.00158	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000701	0.00153	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.0007	0.00153	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000695	0.00152	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GNAS—polycystic ovary syndrome	0.00069	0.00151	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000686	0.0015	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000674	0.00147	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000674	0.00147	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000674	0.00147	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000665	0.00145	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—NCOR1—polycystic ovary syndrome	0.000657	0.00143	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000656	0.00143	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000631	0.00138	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000623	0.00136	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000622	0.00136	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000612	0.00134	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.0006	0.00131	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000597	0.0013	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000596	0.0013	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000587	0.00128	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—MTHFR—polycystic ovary syndrome	0.000581	0.00127	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000579	0.00126	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000552	0.00121	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000546	0.00119	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000543	0.00119	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000542	0.00118	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000542	0.00118	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000497	0.00108	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000494	0.00108	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000488	0.00107	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000478	0.00104	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000477	0.00104	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000473	0.00103	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000473	0.00103	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000471	0.00103	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PPARG—polycystic ovary syndrome	0.000471	0.00103	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000467	0.00102	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—POMC—polycystic ovary syndrome	0.000464	0.00101	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000462	0.00101	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—INS—polycystic ovary syndrome	0.000462	0.00101	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000457	0.000998	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000451	0.000985	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000443	0.000967	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000435	0.000948	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000432	0.000942	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000429	0.000937	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000424	0.000925	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000423	0.000923	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00042	0.000916	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000416	0.000909	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000402	0.000878	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000398	0.000869	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000398	0.000869	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000384	0.000838	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000381	0.000831	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000381	0.000831	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000375	0.000818	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000373	0.000813	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000362	0.000789	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000354	0.000773	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000353	0.00077	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000352	0.000768	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000343	0.000748	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00032	0.000699	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000312	0.000681	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000301	0.000657	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000301	0.000657	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000292	0.000636	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000285	0.000623	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000283	0.000619	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000274	0.000598	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000267	0.000582	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FST—polycystic ovary syndrome	0.00026	0.000567	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000258	0.000564	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000257	0.00056	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000254	0.000554	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000252	0.000551	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000248	0.000541	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00024	0.000524	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00024	0.000523	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000239	0.000522	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000238	0.000519	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000235	0.000512	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000232	0.000507	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000228	0.000498	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000227	0.000495	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000223	0.000486	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000221	0.000482	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000218	0.000475	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000206	0.00045	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000203	0.000444	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000203	0.000444	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000195	0.000425	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000194	0.000423	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000185	0.000403	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000182	0.000397	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	0.00018	0.000393	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000177	0.000386	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000173	0.000377	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000167	0.000366	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000167	0.000365	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000167	0.000365	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000161	0.000352	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00016	0.000349	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000156	0.00034	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000155	0.000338	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000154	0.000336	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000149	0.000326	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000147	0.000322	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000146	0.00032	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000146	0.000319	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000144	0.000314	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000141	0.000307	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000139	0.000303	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000138	0.000302	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000137	0.000298	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000129	0.000281	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000129	0.000281	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000127	0.000277	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000122	0.000267	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00012	0.000262	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	0.00011	0.00024	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000107	0.000233	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000103	0.000225	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000101	0.00022	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	0.0001	0.000219	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	8.99e-05	0.000196	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	8.97e-05	0.000196	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	8.65e-05	0.000189	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	8.61e-05	0.000188	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	8.54e-05	0.000186	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	8.32e-05	0.000182	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	8.32e-05	0.000182	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	8.1e-05	0.000177	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.9e-05	0.000173	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	7.55e-05	0.000165	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	6.37e-05	0.000139	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	6.12e-05	0.000134	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	6.04e-05	0.000132	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	6e-05	0.000131	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.44e-05	0.000119	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	3.76e-05	8.21e-05	CbGpPWpGaD
